1-3 of 3
Lillian Reich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential Administration of Bortezomib, Liposomal Doxorubicin and Dexamethasone (BDD) Followed by Thalidomide and Dexamethasone (TD) Results in Rapid Control of Untreated High-Risk Multiple Myeloma (MM) and Improves Depth of Response

Heather Landau, MD, Hani Hassoun, MD, Adam Cohen, MD, Elizabeth Hoover, Tarun Kewalramani, MD, Adam Boruchov, MD, Virginia Klimek, MD, Lillian Reich, MD, Elyn Riedel, Neeta Pandit-Taskar, MD, Stephen D. Nimer, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2008) 112 (11): 3712.
https://doi.org/10.1182/blood.V112.11.3712.3712
Published: 2008
Journal Articles

Adjuvant Dexamethasone (D) ± Thalidomide (T) Improves Hematologic and Organ Responses after Risk-Adapted High-Dose Melphalan with Autologous Stem Cell Transplant (SCT) for Patients with Systemic AL Amyloidosis (AL).

Adam D. Cohen, MD, Ping Zhou, MD, PhD, Lillian Reich, MD, Hani Hassoun, MD, Julie Teruya-Feldstein, MD, Daniel A. Filippa, MD, Martin Fleisher, PhD, Stephen D. Nimer, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2005) 106 (11): 1163.
https://doi.org/10.1182/blood.V106.11.1163.1163
Published: 2005
Journal Articles

Risk-Adapted Intravenous Melphalan Followed by Adjuvant Dexamethasone (D) and Thalidomide (T) for Newly Diagnosed Patients with Systemic AL Amyloidosis (AL): Interim Results of a Phase II Study.

Adam D. Cohen, Ping Zhou, Lillian Reich, Alice Quinn, Sophia Fircanis, Lisa Drake, Cyrus Hedvat, Julie Teruya-Feldstein, Daniel A. Filippa, Martin Fleisher, Raymond L. Comenzo
Journal: Blood
Blood (2004) 104 (11): 542.
https://doi.org/10.1182/blood.V104.11.542.542
Published: 2004